Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Curr Opin Infect Dis ; 26(6): 545-50, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24152763

RESUMO

PURPOSE OF REVIEW: The recent outbreak of fungal meningitis related to contaminated methylprednisolone acetate injections represents an important cause of morbidity and continues to be a significant public health problem in the United States. RECENT FINDINGS: As of August 2013, there have been 749 cases and 63 deaths in 20 states associated with epidemic fungal meningitis, most of these because of Exserohilum rostratum. Clinical experience in managing these cases has grown dramatically in the last several months; most patients require at least 6 months of antifungal therapy for complicated disease. Most patients are treated with voriconazole, with or without liposomal amphotericin B, for central nervous system and paraspinal complications of the disease. For disease involving the sacroiliac and peripheral joints, voriconazole alone has been preferred. MRI spine imaging has identified several cases of asymptomatic disease, suggesting an aggressive diagnostic approach to exposed asymptomatic patients. Mortality remains low (<10%), but morbidity relating to persistent symptoms and treatment-associated toxicity is high. SUMMARY: The ongoing fungal meningitis epidemic demonstrates an important achievement for the public health community. Important questions remain relating to the diagnosis, management, and long-term outcomes of these patients. Important research questions pertaining to specific risks influencing disease manifestations remain unanswered.


Assuntos
Ascomicetos/classificação , Surtos de Doenças/prevenção & controle , Contaminação de Medicamentos , Meningite Fúngica/epidemiologia , Anti-Inflamatórios/efeitos adversos , Antifúngicos/uso terapêutico , Humanos , Meningite Fúngica/induzido quimicamente , Meningite Fúngica/tratamento farmacológico , Meningite Fúngica/microbiologia , Metilprednisolona/efeitos adversos , Metilprednisolona/análogos & derivados , Acetato de Metilprednisolona , Estados Unidos/epidemiologia
2.
Indian J Med Sci ; 56(7): 325-9, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12645168

RESUMO

The aim of the study was to find out the prevalence of fungal meningitis among AIDS cases and to assess the prognosis of fungal meningitis among HIV positive & negative subjects. The study comprised of 15 & 10 cases of fungal meningitis among HIV positive & negative subjects respectively during the study period 1992-2001. India ink preparation and Gram's staining procedures were carried out on the centrifuged CSF deposits. The CSF deposits were also used for bacterial and fungal culture. In the present study the prevalence of fungal meningitis was noted among 15 (3.1%) of 483 AIDS cases. Twelve of them had cryptococcal meningitis while 3 were infected with Candida albicans. Four AIDS cases presented fungal meningitis as a primary opportunistic infection and HIV status was confirmed in 4 of them after the diagnosis of fungal meningitis. 13 of the 15 cases were in the age group 26-40 yrs while one was 55 yrs old and the other 16 month old child; these two cases had blood transfusion transmitted and vertically transmitted mode of HIV transmission respectively. Further, only two of 15 cases were females and both acquired HIV infection through blood transfusion. Overall prognosis of fungal meningitis was poor among HIV positives and 7 of the 15 cases died in hospital within 2-3 weeks after diagnosis of cryptococcal meningitis. Among HIV negative subjects, ten cases of fungal meningitis (3 with Candida albicans and 7 with Cryptococcous neoformans) were noted at our end and nine of them had immunocompromised status (3 cases of renal transplant on immunosuppressives, 3 cases neonates/infant and 2 diabetic subjects. The fungal meningitis is one of the important causes of morbidity & mortality among immunocompromised among HIV positive subjects.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Soropositividade para HIV/epidemiologia , Meningite Fúngica/epidemiologia , Adulto , Idoso , Candidíase/induzido quimicamente , Candidíase/epidemiologia , Comorbidade , Criptococose/induzido quimicamente , Criptococose/epidemiologia , Transmissão de Doença Infecciosa , Feminino , Soronegatividade para HIV , Soropositividade para HIV/transmissão , Humanos , Imunossupressores/efeitos adversos , Índia/epidemiologia , Lactente , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Masculino , Meningite Fúngica/induzido quimicamente , Pessoa de Meia-Idade , Prevalência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA